Patient-to-patient transmission of natalizumab-associated PML?
Institute of Clinical Neuroimmunology, Biomedical Center and University Hospital, Ludwig Maximilians University, Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Ludwig Maximilians University, Munich, Germany.
Reinhard
R
Hohlfeld
Institute of Clinical Neuroimmunology, Biomedical Center and University Hospital, Ludwig Maximilians University, Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Ludwig Maximilians University, Munich, Germany.
Joachim
J
Havla
Institute of Clinical Neuroimmunology, Biomedical Center and University Hospital, Ludwig Maximilians University, Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Ludwig Maximilians University, Munich, Germany.
Tania
T
Kümpfel
D006801:Humans; D007155:Immunologic Factors; D007577:JC Virus / Q000276:immunology; D007968:Leukoencephalopathy, Progressive Multifocal; D000069442:Natalizumab
D007155:Immunologic Factors; D000069442:Natalizumab